Know Labs, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
William Arthur Owens, a Director of Know Labs, Inc., received 120,000 shares of common stock on August 12, 2026.
Ichiro Takesako, a Director of Know Labs, Inc., received 120,000 shares of common stock on August 12, 2026.
Jon Pepper, a Director of Know Labs, Inc., received 120,000 shares of common stock on August 12, 2026.
Larry K Ellingson, a Director of Know Labs, Inc., received 120,000 shares of common stock on August 12, 2026.
USBC, Inc. director Linda Jenkinson's stock options for 10 million shares were repriced from $1.10 to $0.37 per share under the 2021 Equity Incentive Plan.
USBC, Inc. CFO Kitty B. Payne's stock options for 3.75 million shares were repriced from $1.10 to $0.37 per share.
USBC, Inc. CFO Kitty B. Payne saw 1.79 million stock options repriced to $1.10 and received a new grant of 1.96 million options, totaling 3.75 million beneficially owned.
USBC Director Linda Jenkinson saw 4.76 million stock options repriced to $1.10 and received a new grant of 5.24 million options, totaling 10 million beneficially owned.
USBC, Inc.'s Chief Operating Officer, Kirk Chapman, received a repricing of 7.14 million stock options to $1.10 per share and a new grant of 7.86 million options at the same price.
USBC, Inc. Director Linda Jenkinson received a grant of options to purchase 4.76 million shares of common stock under the company's 2021 Equity Incentive Plan.
USBC, Inc. Chief Operating Officer Kirk Chapman was granted options to purchase 7.14 million shares of common stock at an exercise price of $2.45 per share.
KNOW LABS, INC. CFO Kitty B. Payne was granted options to purchase 1.79 million shares of common stock at an exercise price of $2.45, vesting over four years.
KNOW LABS Director Ronald P. Erickson increased his beneficial ownership through a stock award and a significant preferred stock redemption involving an affiliated entity.
Former Chief Financial Officer Peter J. Conley acquired 107,500 shares of KNOW LABS, INC. common stock indirectly through Prestwick Associates LLC.
KNOW LABS, INC. CEO and Chairman Ronald P. Erickson has converted $1,184,066 in promissory notes held by an affiliated entity into Series H Convertible Preferred Stock, alongside other changes in his beneficial ownership of company securities.
Director Larry Ellingson reports acquisition of 25,000 shares of Know Labs, Inc. at $0.44 per share.
Director Ichiro John Paul Takesako reports acquisition of Know Labs shares and warrant holdings.
Director Jon Pepper reports acquiring 25,000 shares of Know Labs, Inc. at $0.44 per share on May 5, 2025, increasing his direct holdings.
Peter J. Conley, CFO of Know Labs, Inc., reports the acquisition of 50,000 shares of common stock at $0.44 per share on May 5, 2025.
Know Labs CEO Ronald Erickson reports acquiring 100,000 shares of common stock at $0.44 per share on May 5, 2025, while also disposing of 137,202 shares.
Director William Owens reports the acquisition of 25,000 shares of Know Labs, Inc. common stock at $0.44 per share on May 5, 2025.
Director John Cronin reports acquisition of Know Labs shares both directly and indirectly through ipCapital Group, Inc.
John Cronin, a director at Know Labs, filed an amended Form 4 to correct the date of the earliest transaction from September 11, 2024, to September 24, 2024, while also reporting the acquisition of an option to purchase 1,000,000 shares of common stock.
Director John E. Cronin reports acquisition of 1,000,000 options to purchase Know Labs, Inc. common stock.
Ronald P. Erickson, a director, officer, and chairman of Know Labs, Inc., filed a Form 4 indicating an extension of warrant expiration dates, maintaining a substantial stake in the company.
Director Jon Pepper reported a gift of 14,000 common stock shares and maintains beneficial ownership of 514,000 shares in Know Labs, Inc.